Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq

Yanting Shen; Lu Bu; Rui Li; Zhenzhu Chen; Fei Tian; Na Lu; Qinyu Ge; Yunfei Bai; Zuhong Lu

doi:10.18632/oncotarget.15855

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq

Yanting Shen, Lu Bu, Rui Li, Zhenzhu Chen, Fei Tian, Na Lu, Qinyu Ge _, Yunfei Bai and Zuhong Lu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:27976-27989. https://doi.org/10.18632/oncotarget.15855

Metrics: PDF 1753 views | HTML 2225 views | ?

Abstract

Yanting Shen1,2, Lu Bu3, Rui Li1, Zhenzhu Chen1, Fei Tian1, Na Lu2, Qinyu Ge2, Yunfei Bai2, Zuhong Lu1,2

1Research Center for Learning Science, Southeast University, Nanjing, Jiangsu Province 210096, PR China

2State Key Laboratory of Bioelectronics, Southeast University, Nanjing, Jiangsu Province 210096, PR China

3Department of Interventional Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, Jiangsu Province 210009, PR China

Correspondence to:

Qinyu Ge, email: [email protected]

Keywords: hepatic carcinoma, metastasis, PBMC, tumor heterogeneity, diagnosis

Received: December 06, 2016 Accepted: February 20, 2017 Published: March 02, 2017

ABSTRACT

Tumor metastasis is a multistep process involving a number of genetic alterations so that the genetic diagnosis is got increasingly attentions today. The aim of this study was to use RNA-seq to screen the effective differential expression genes in the peripheral blood mononuclear cells for the hepatic carcinoma with metastasis. The results showed that hepatic carcinoma samples gathered according to different metastasis. CCL3, CCL3L1, JUN, IL8, and IL1B were identified in inflammation mediated by chemokine and cytokine signaling pathway (P00031) in the hepatic carcinoma samples with metastasis, and subsequently confirmed by quantitative real-time polymerase chain reaction. In conclusions, CCL3, CCL3L1, JUN, IL8, and IL1B have the potential to be considered as candidates for future molecular diagnosis of the hepatic carcinoma with metastasis. This work may provide us with new visions into the metastasis process and potential efficient clinical diagnosis in the future.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15855

Publication Alerts

Research Papers:

Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq

Abstract